Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolism study of radiolabeled PF-06821497 in healthy adult men
NL-OMON60852Phase 1Completed
- Sponsor
- Pfizer
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of mevrometostat, sponsored by Pfizer. Started Jul 2024; status: completed.
02
Drugs
mevrometostat
Beyond the preview
Go deeper on NL-OMON60852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60852.